Venous thromboembolism (VTE), comprising deep vein thrombosis (DVT) and pulmonary embolism (PE), is a frequently recurring and serious complication after cessation of anticoagulant therapy. Several studies indicate that 10 years after cessation of anticoagulant therapy the risk of recurrent VTE is 39.9% and nearly 50% for unprovoked VTE
The aim of this review is to outline recent randomized controlled trials and strategies that have te...
In adults who completed a course of anticoagulant therapy after a first-ever, unprovoked venous thro...
Introduction: Aspirin is widely used for the prevention of venous thromboembolism (VTE) after total ...
While there is conclusive evidence that aspirin plays a role in reducing the risk of clinically rele...
Background About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2...
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 ...
Abstract Acetylsalicylic acid (ASA) or aspirin is a well-known anticoagulant that provides relativel...
Approximately 20 % of patients with unprovoked venous thromboembolism (VTE) have a recurrence within...
Background—In patients with a first unprovoked venous thromboembolism (VTE) the risk of recurrent VT...
BACKGROUND: In patients with a first unprovoked venous thromboembolism (VTE) the risk of recurrent V...
Aspirin reduced recurrence of venous thromboembolism (VTE) after a first-ever, unprovoked VT
The risk of recurrent thromboembolic disorders in the 10-year period following an episode of unprovo...
Patients who have had an unprovoked deep venous thrombosis (DVT) or pulmonary embolus (PE) are at a ...
After patients with unprovoked venous thromboembolism (VTE) complete a 6- to 18-month course of oral...
Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recur...
The aim of this review is to outline recent randomized controlled trials and strategies that have te...
In adults who completed a course of anticoagulant therapy after a first-ever, unprovoked venous thro...
Introduction: Aspirin is widely used for the prevention of venous thromboembolism (VTE) after total ...
While there is conclusive evidence that aspirin plays a role in reducing the risk of clinically rele...
Background About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2...
BACKGROUND: About 20% of patients with unprovoked venous thromboembolism have a recurrence within 2 ...
Abstract Acetylsalicylic acid (ASA) or aspirin is a well-known anticoagulant that provides relativel...
Approximately 20 % of patients with unprovoked venous thromboembolism (VTE) have a recurrence within...
Background—In patients with a first unprovoked venous thromboembolism (VTE) the risk of recurrent VT...
BACKGROUND: In patients with a first unprovoked venous thromboembolism (VTE) the risk of recurrent V...
Aspirin reduced recurrence of venous thromboembolism (VTE) after a first-ever, unprovoked VT
The risk of recurrent thromboembolic disorders in the 10-year period following an episode of unprovo...
Patients who have had an unprovoked deep venous thrombosis (DVT) or pulmonary embolus (PE) are at a ...
After patients with unprovoked venous thromboembolism (VTE) complete a 6- to 18-month course of oral...
Patients who have had a first episode of unprovoked venous thromboembolism have a high risk of recur...
The aim of this review is to outline recent randomized controlled trials and strategies that have te...
In adults who completed a course of anticoagulant therapy after a first-ever, unprovoked venous thro...
Introduction: Aspirin is widely used for the prevention of venous thromboembolism (VTE) after total ...
DOI
Add to ORKG